Cleo Diagnostics (COV.AX) Stock Price
Cleo Diagnostics Price
Over the last 2 years Cleo Diagnostics grew revenue by 228.1% annually, reaching 1.18 M AUD. For Cleo Diagnostics, the net margin of -337.5% is up versus -1,571.1% a few years ago.
Cleo Diagnostics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cleo Diagnostics business model & stock analysis
Frequently asked questions about Cleo Diagnostics
Converted at the current exchange rate, the Cleo Diagnostics share trades at 0.19 EUR (0.31 AUD).
The revenue cannot currently be calculated for Cleo Diagnostics.
The profit of Cleo Diagnostics is -5.94 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cleo Diagnostics is currently -7.04. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cleo Diagnostics stock.
The P/S cannot be calculated for Cleo Diagnostics currently.
The Eulerpool Quality Score for Cleo Diagnostics is 2/10.
The ISIN of Cleo Diagnostics is AU0000288045. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Cleo Diagnostics is COV.AX. The ticker symbol is used to trade Cleo Diagnostics shares on the stock exchange.
Cleo Diagnostics stock
Cleo Diagnostics Peer Group
Cleo Diagnostics FIGI
All fundamentals and in-depth analysis of Cleo Diagnostics
Our stock analysis for Cleo Diagnostics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cleo Diagnostics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.